TECH vs TWST · P/E 65, rev $1.22B vs $5.16B cap
Bio-Techne Corp (TECH) versus Twist Bioscience Corp (TWST) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Twist Bioscience Corp (TWST) is a diagnostics & research company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
TWST does not have a complete income-statement cache yet.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TWST currently screens at market cap $5.16B.
Not investment advice. Open the TECH and TWST stock pages for the full models.
Not investment advice.